发明名称 |
USE OF FGFR MUTANT GENE PANELS IN IDENTIFYING CANCER PATIENTS THAT WILL BE RESPONSIVE TO TREATMENT WITH AN FGFR INHIBITOR |
摘要 |
Disclosed herein are methods of identifying a cancer patient that will be responsive to treatment with a fibroblast growth factor receptor (FGFR) inhibitor and methods of treating cancer patients. The methods involve evaluating a biological sample from the patient for the presence of one or more FGFR mutants from a FGFR mutant gene panel. Kits and primers for identifying the presence of one or more FGFR mutant genes in a biological sample are also disclosed herein. |
申请公布号 |
WO2016048833(A2) |
申请公布日期 |
2016.03.31 |
申请号 |
WO2015US50996 |
申请日期 |
2015.09.18 |
申请人 |
JANSSEN PHARMACEUTICA NV |
发明人 |
KARKERA, JAYAPRAKASH;PLATERO, SUSO JESUS |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|